Serina Therapeutics, Inc. Annual Operating Margin in % from 2017 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Serina Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2017 to 2024.
  • Serina Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -30.4K %, a 30576% decline year-over-year.
  • Serina Therapeutics, Inc. annual Operating Margin for 2024 was -30.4K %, a 30576% decline from 2023.
  • Serina Therapeutics, Inc. annual Operating Margin for 2023 was -99.2 %, a 99.5% increase from 2022.
  • Serina Therapeutics, Inc. annual Operating Margin for 2022 was -20.5K %, a 272% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -30.4K -30.3K -30576% Jan 1, 2024 Dec 31, 2024
2023 -99.2 +20.4K +99.5% Jan 1, 2023 Dec 31, 2023
2022 -20.5K -15K -272% Jan 1, 2022 Dec 31, 2022
2021 -5.51K -2.71K -96.9% Jan 1, 2021 Dec 31, 2021
2020 -2.8K -2.07K -285% Jan 1, 2020 Dec 31, 2020
2019 -727 +78.7 +9.77% Jan 1, 2019 Dec 31, 2019
2018 -806 -331 -69.7% Jan 1, 2018 Dec 31, 2018
2017 -475 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.